参考文献/References:
[1] SHIRAKI M. Pathogenesis of fracture will be important in the research work of osteoporosis[J].Nippon Rinsho,2006,64(9):1597-1604.
[2] 刘忠厚.中国人骨质疏松症的建议诊断标准(第二稿)[J].中国骨质疏松杂志,2000,6(1):2.
[3] 武峻艳.中医学对骨质疏松症的认识[J].中医杂志,2005,46(增刊):204-206.
[4] 罗毅文,黄宏兴,刘海全,等.中医药治疗骨质疏松症的研究进展[J].湖南中医杂志,2003,19(4):60.
[5] 鲍加荣,杨继文,李树峰.淫羊藿苷对去卵巢大鼠骨质疏松症的影响[J].卫生研究,2005,34(2):191-93.
[6] 丁桂芝,周勇,李榕,等.补肾法对骨质疏松大鼠骨代谢影响的作用机理探讨[J].中国中医骨伤科杂志,2008,16(3):1-4.
[7] 姚共和,谢林,曹寅生.金刚健骨片对去卵巢模型鼠细胞因子影响的实验研究[J].湖南中医学院学报,2002,22(2):8-9, 14.
[8] SANGUINETI R, STORACE D, MONACELLI F, et al. Pentosidine effects on human osteoblasts in vitro[J].Ann N Y Acad Sci, 2008,1126:166-172.
[9] BEKKER P J, HOLLOWAY D, NAKANISHI A,et al. The effect of single dose of osteoprotegerin in postmenopausal women[J].J Bone Miner Re,2001, 16(2):348-360.
[10] YASUDA H. Osteoprotegerin(OPG/OCIF)inhibits bone destruction in rheumatoid arthritis models[J].Clin Calcium, 2001,11(5):602-607.